Recent Advances in the Study on Resveratrol

Appropriate long-term drinking of red wine is associated with a reduced risk for lifestyle-related diseases such as cardiovascular disease and cancer, making resveratrol, a constituent of grapes and various other plants, an attractive compound to be studied. Historically, resveratrol has been identi...

Full description

Saved in:
Bibliographic Details
Published in:Biological & pharmaceutical bulletin 2012/03/01, Vol.35(3), pp.273-279
Main Authors: Nakata, Rieko, Takahashi, Satoru, Inoue, Hiroyasu
Format: Article
Language:English
Subjects:
Animals
cyclooxygenase
Cyclooxygenase Inhibitors - pharmacology
endothelial nitric oxide synthase
Humans
Nitric Oxide Synthase Type III - metabolism
peroxisome proliferator-activated receptor
Peroxisome Proliferator-Activated Receptors - metabolism
Resveratrol
silent mating type information regulation 2 homolog 1
Sirtuin 1 - metabolism
Stilbenes - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c688t-796aec2f983965c92df0e111f3e7596195ed338b1c20e53d84aa43f0129355ad3
cites cdi_FETCH-LOGICAL-c688t-796aec2f983965c92df0e111f3e7596195ed338b1c20e53d84aa43f0129355ad3
container_end_page 279
container_issue 3
container_start_page 273
container_title Biological & pharmaceutical bulletin
container_volume 35
creator Nakata, Rieko
Takahashi, Satoru
Inoue, Hiroyasu
description Appropriate long-term drinking of red wine is associated with a reduced risk for lifestyle-related diseases such as cardiovascular disease and cancer, making resveratrol, a constituent of grapes and various other plants, an attractive compound to be studied. Historically, resveratrol has been identified as a phytoalexin, antioxidant, cyclooxygenase (COX) inhibitor, peroxisome proliferator-activated receptor (PPAR) activator, endothelial nitric oxide synthase (eNOS) inducer, silent mating type information regulation 2 homolog 1 (SIRT1) activator, and more. Despite scepticism concerning the biological availability of resveratrol, a growing body of in vivo evidence indicates that resveratrol has protective effects in several stress and disease models. Here, we provide a review of the studies on resveratrol, especially with respect to COX, PPAR, and eNOS activities, and discuss its potential for promoting human health.
doi_str_mv 10.1248/bpb.35.273
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_926156975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>926156975</sourcerecordid><originalsourceid>FETCH-LOGICAL-c688t-796aec2f983965c92df0e111f3e7596195ed338b1c20e53d84aa43f0129355ad3</originalsourceid><addsrcrecordid>eNpdkEGLFDEQhYMo7rh68QdIgwdB6TGVSrqTkyyLrsKCsOo5pNPVbg89yZh0L-y_N0PvrOCl6lBfvar3GHsNfAtC6o_dodui2ooWn7ANoGxrJUA9ZRtuQNcNKH3GXuS845y3XOBzdiYEaoEAG_bhhjyFubro71zwlKsxVPMtVT_mpb-vYqhuKN9RcnOK00v2bHBTplcP_Zz9-vL55-XX-vr71bfLi-vaN1rPdWsaR14MRqNplDeiHzgBwIDUKtOAUdQj6g684KSw19I5iQMHYVAp1-M5e7fqHlL8s1Ce7X7MnqbJBYpLtkYUT41pVSHf_kfu4pJCec6ClKaYlBIK9X6lfIo5JxrsIY17l-4tcHtM0JYELSpbEizwmwfJpdtT_4ieIivA1QqU6ejdFMM0Bvp32Oe2G-MUrSiOLOeoOJYGlhf5YzHQKKmBF6VPq9Iuz-43PZ5yaR79RKevcC3H7dPE37pkKeBfkamVwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449382441</pqid></control><display><type>article</type><title>Recent Advances in the Study on Resveratrol</title><source>Free Full-Text Journals in Chemistry</source><creator>Nakata, Rieko ; Takahashi, Satoru ; Inoue, Hiroyasu</creator><creatorcontrib>Nakata, Rieko ; Takahashi, Satoru ; Inoue, Hiroyasu ; bDepartment of Immunobiology school of Pharmacy and Pharmaceutical Sciences Mukogawa Women's University ; aDepartment of Food Science and Nutrition Nara Women's University</creatorcontrib><description>Appropriate long-term drinking of red wine is associated with a reduced risk for lifestyle-related diseases such as cardiovascular disease and cancer, making resveratrol, a constituent of grapes and various other plants, an attractive compound to be studied. Historically, resveratrol has been identified as a phytoalexin, antioxidant, cyclooxygenase (COX) inhibitor, peroxisome proliferator-activated receptor (PPAR) activator, endothelial nitric oxide synthase (eNOS) inducer, silent mating type information regulation 2 homolog 1 (SIRT1) activator, and more. Despite scepticism concerning the biological availability of resveratrol, a growing body of in vivo evidence indicates that resveratrol has protective effects in several stress and disease models. Here, we provide a review of the studies on resveratrol, especially with respect to COX, PPAR, and eNOS activities, and discuss its potential for promoting human health.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.35.273</identifier><identifier>PMID: 22382311</identifier><language>eng</language><publisher>Japan: The Pharmaceutical Society of Japan</publisher><subject>Animals ; cyclooxygenase ; Cyclooxygenase Inhibitors - pharmacology ; endothelial nitric oxide synthase ; Humans ; Nitric Oxide Synthase Type III - metabolism ; peroxisome proliferator-activated receptor ; Peroxisome Proliferator-Activated Receptors - metabolism ; Resveratrol ; silent mating type information regulation 2 homolog 1 ; Sirtuin 1 - metabolism ; Stilbenes - pharmacology</subject><ispartof>Biological and Pharmaceutical Bulletin, 2012/03/01, Vol.35(3), pp.273-279</ispartof><rights>2012 The Pharmaceutical Society of Japan</rights><rights>Copyright Japan Science and Technology Agency 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c688t-796aec2f983965c92df0e111f3e7596195ed338b1c20e53d84aa43f0129355ad3</citedby><cites>FETCH-LOGICAL-c688t-796aec2f983965c92df0e111f3e7596195ed338b1c20e53d84aa43f0129355ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22382311$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakata, Rieko</creatorcontrib><creatorcontrib>Takahashi, Satoru</creatorcontrib><creatorcontrib>Inoue, Hiroyasu</creatorcontrib><creatorcontrib>bDepartment of Immunobiology school of Pharmacy and Pharmaceutical Sciences Mukogawa Women's University</creatorcontrib><creatorcontrib>aDepartment of Food Science and Nutrition Nara Women's University</creatorcontrib><title>Recent Advances in the Study on Resveratrol</title><title>Biological &amp; pharmaceutical bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>Appropriate long-term drinking of red wine is associated with a reduced risk for lifestyle-related diseases such as cardiovascular disease and cancer, making resveratrol, a constituent of grapes and various other plants, an attractive compound to be studied. Historically, resveratrol has been identified as a phytoalexin, antioxidant, cyclooxygenase (COX) inhibitor, peroxisome proliferator-activated receptor (PPAR) activator, endothelial nitric oxide synthase (eNOS) inducer, silent mating type information regulation 2 homolog 1 (SIRT1) activator, and more. Despite scepticism concerning the biological availability of resveratrol, a growing body of in vivo evidence indicates that resveratrol has protective effects in several stress and disease models. Here, we provide a review of the studies on resveratrol, especially with respect to COX, PPAR, and eNOS activities, and discuss its potential for promoting human health.</description><subject>Animals</subject><subject>cyclooxygenase</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>endothelial nitric oxide synthase</subject><subject>Humans</subject><subject>Nitric Oxide Synthase Type III - metabolism</subject><subject>peroxisome proliferator-activated receptor</subject><subject>Peroxisome Proliferator-Activated Receptors - metabolism</subject><subject>Resveratrol</subject><subject>silent mating type information regulation 2 homolog 1</subject><subject>Sirtuin 1 - metabolism</subject><subject>Stilbenes - pharmacology</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpdkEGLFDEQhYMo7rh68QdIgwdB6TGVSrqTkyyLrsKCsOo5pNPVbg89yZh0L-y_N0PvrOCl6lBfvar3GHsNfAtC6o_dodui2ooWn7ANoGxrJUA9ZRtuQNcNKH3GXuS845y3XOBzdiYEaoEAG_bhhjyFubro71zwlKsxVPMtVT_mpb-vYqhuKN9RcnOK00v2bHBTplcP_Zz9-vL55-XX-vr71bfLi-vaN1rPdWsaR14MRqNplDeiHzgBwIDUKtOAUdQj6g684KSw19I5iQMHYVAp1-M5e7fqHlL8s1Ce7X7MnqbJBYpLtkYUT41pVSHf_kfu4pJCec6ClKaYlBIK9X6lfIo5JxrsIY17l-4tcHtM0JYELSpbEizwmwfJpdtT_4ieIivA1QqU6ejdFMM0Bvp32Oe2G-MUrSiOLOeoOJYGlhf5YzHQKKmBF6VPq9Iuz-43PZ5yaR79RKevcC3H7dPE37pkKeBfkamVwg</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Nakata, Rieko</creator><creator>Takahashi, Satoru</creator><creator>Inoue, Hiroyasu</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>2012</creationdate><title>Recent Advances in the Study on Resveratrol</title><author>Nakata, Rieko ; Takahashi, Satoru ; Inoue, Hiroyasu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c688t-796aec2f983965c92df0e111f3e7596195ed338b1c20e53d84aa43f0129355ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>cyclooxygenase</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>endothelial nitric oxide synthase</topic><topic>Humans</topic><topic>Nitric Oxide Synthase Type III - metabolism</topic><topic>peroxisome proliferator-activated receptor</topic><topic>Peroxisome Proliferator-Activated Receptors - metabolism</topic><topic>Resveratrol</topic><topic>silent mating type information regulation 2 homolog 1</topic><topic>Sirtuin 1 - metabolism</topic><topic>Stilbenes - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakata, Rieko</creatorcontrib><creatorcontrib>Takahashi, Satoru</creatorcontrib><creatorcontrib>Inoue, Hiroyasu</creatorcontrib><creatorcontrib>bDepartment of Immunobiology school of Pharmacy and Pharmaceutical Sciences Mukogawa Women's University</creatorcontrib><creatorcontrib>aDepartment of Food Science and Nutrition Nara Women's University</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological &amp; pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakata, Rieko</au><au>Takahashi, Satoru</au><au>Inoue, Hiroyasu</au><aucorp>bDepartment of Immunobiology school of Pharmacy and Pharmaceutical Sciences Mukogawa Women's University</aucorp><aucorp>aDepartment of Food Science and Nutrition Nara Women's University</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent Advances in the Study on Resveratrol</atitle><jtitle>Biological &amp; pharmaceutical bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>2012</date><risdate>2012</risdate><volume>35</volume><issue>3</issue><spage>273</spage><epage>279</epage><pages>273-279</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>Appropriate long-term drinking of red wine is associated with a reduced risk for lifestyle-related diseases such as cardiovascular disease and cancer, making resveratrol, a constituent of grapes and various other plants, an attractive compound to be studied. Historically, resveratrol has been identified as a phytoalexin, antioxidant, cyclooxygenase (COX) inhibitor, peroxisome proliferator-activated receptor (PPAR) activator, endothelial nitric oxide synthase (eNOS) inducer, silent mating type information regulation 2 homolog 1 (SIRT1) activator, and more. Despite scepticism concerning the biological availability of resveratrol, a growing body of in vivo evidence indicates that resveratrol has protective effects in several stress and disease models. Here, we provide a review of the studies on resveratrol, especially with respect to COX, PPAR, and eNOS activities, and discuss its potential for promoting human health.</abstract><cop>Japan</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>22382311</pmid><doi>10.1248/bpb.35.273</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-6158
ispartof Biological and Pharmaceutical Bulletin, 2012/03/01, Vol.35(3), pp.273-279
issn 0918-6158
1347-5215
language eng
recordid cdi_proquest_miscellaneous_926156975
source Free Full-Text Journals in Chemistry
subjects Animals
cyclooxygenase
Cyclooxygenase Inhibitors - pharmacology
endothelial nitric oxide synthase
Humans
Nitric Oxide Synthase Type III - metabolism
peroxisome proliferator-activated receptor
Peroxisome Proliferator-Activated Receptors - metabolism
Resveratrol
silent mating type information regulation 2 homolog 1
Sirtuin 1 - metabolism
Stilbenes - pharmacology
title Recent Advances in the Study on Resveratrol
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A44%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20Advances%20in%20the%20Study%20on%20Resveratrol&rft.jtitle=Biological%20&%20pharmaceutical%20bulletin&rft.au=Nakata,%20Rieko&rft.aucorp=bDepartment%20of%20Immunobiology%20school%20of%20Pharmacy%20and%20Pharmaceutical%20Sciences%20Mukogawa%20Women's%20University&rft.date=2012&rft.volume=35&rft.issue=3&rft.spage=273&rft.epage=279&rft.pages=273-279&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.35.273&rft_dat=%3Cproquest_cross%3E926156975%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c688t-796aec2f983965c92df0e111f3e7596195ed338b1c20e53d84aa43f0129355ad3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1449382441&rft_id=info:pmid/22382311&rfr_iscdi=true